More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.55B
EPS
-0.62
P/E ratio
--
Price to sales
0.79
Dividend yield
--
Beta
1.990981
Previous close
$29.10
Today's open
$28.32
Day's range
$27.48 - $28.62
52 week range
$10.43 - $29.90
show more
CEO
Drew Wilkerson
Employees
9873
Headquarters
Charlotte, NC
Exchange
New York Stock Exchange
Shares outstanding
164926128
Issue type
Common Stock
Industrials
Transportation
RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains
CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported strong third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “We exceeded the high end of our third-quarter profit outlook, demonstrating the momentum we're building across RXO. We continued to take market share in Brokerage, and achieved a 3 percent increase in truckload volume, outperforming the market. We achieved a 900 basis-point sequential increase in truckload spot mix, which helped drive the best seque.
Business Wire • 13 hours ago

RXO (RXO) Q3 Earnings and Revenues Top Estimates
RXO (RXO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.
Zacks Investment Research • 11 hours ago

RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • 9 hours ago

Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Oct 22, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
GlobeNewsWire • Oct 20, 2026

Top 3 Industrials Stocks That May Collapse This Quarter
As of Oct. 19, 2026, three stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Benzinga • Oct 19, 2026

Freight Broker C.H. Robinson to Buy Smaller Rival RXO
Plus, the U.S. will temporarily allow highway sales of dyed diesel, and Persian Gulf oil producers pay millions to move crude.
WSJ • Oct 6, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)
NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating RXO, Inc. (NYSE: RXO) related to its sale to C.H.
PRNewsWire • Oct 6, 2026

RXO (RXO) Is Attractively Priced Despite Fast-paced Momentum
RXO (RXO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Oct 6, 2026

RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RXO Inc. (NYSE: RXO) to C.H. Robinson Worldwide, Inc. (NasdaqGS: CHRW). Under the terms of the proposed transaction, shareholders of RXO will receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share. Upon closing of the Proposed Transaction, RXO shareh.
Business Wire • Oct 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell RXO Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.